GGrantIndex
← Leaderboards

Christine P Grady

Clinical Center

$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

By mechanism

Top collaborators

No co-investigators on record.

Most similar at Clinical Center

Same institution · by research overlap

Others in their field

Top investigators on “Ethics

Research focus

EthicsParticipantClinical ResearchHealthy VolunteerInterviewSurveysPublishingQuestionnairesConsentEnrollmentDecision MakingVolunteerInformed ConsentData AnalysesBenefits And RisksBehavioral /Social Science Research TagConsent FormsManuscriptsComprehensionDesignHuman SubjectInstitutionRandomizedWillingness

Grant awards (64)

Ethical Experiences of Registered Nurses$0
ZIA · FY2024 · CL · contact PI
Challenges in Research Ethics$0
ZIA · FY2024 · CL · contact PI
Ethical Experiences of Registered Nurses$0
ZIA · FY2023 · CL · contact PI
Impact of Opioid-Related Emergencies on First Responders$0
ZIA · FY2023 · CL · contact PI
Randomized informed consent$0
ZIA · FY2022 · CL · contact PI
Ethical Problems of Registered Nurses and Social Workers$0
ZIA · FY2022 · CL · contact PI
Impact of Opioid-Related Emergencies on First Responders$0
ZIA · FY2022 · CL · contact PI
Motivations, expectations,and decision making of sickle cell patients in clinical research$0
ZIA · FY2021 · CL · contact PI
Randomized informed consent$0
ZIA · FY2021 · CL · contact PI
Impact of Opioid-Related Emergencies on First Responders$0
ZIA · FY2021 · CL · contact PI
Randomized informed consent$0
ZIA · FY2020 · CL · contact PI
Motivations, expectations,and decision making of sickle cell patients in clinical research$0
ZIA · FY2020 · CL · contact PI
Impact of Opioid-Related Emergencies on First Responders$0
ZIA · FY2020 · CL · contact PI
Randomized informed consent$0
ZIA · FY2019 · CL · contact PI
Motivations for participation in phase 1 drug development trials$0
ZIA · FY2018 · CL · contact PI
Randomized informed consent$0
ZIA · FY2018 · CL · contact PI
Parental permission and adolescent assent and decision making in clinical resear$0
ZIA · FY2017 · CL · contact PI
Motivations for participation in phase 1 drug development trials$0
ZIA · FY2017 · CL · contact PI
Randomized informed consent$0
ZIA · FY2017 · CL · contact PI
Parental permission and adolescent assent and decision making in clinical resear$0
ZIA · FY2016 · CL · contact PI
Motivations for participation in phase 1 drug development trials$0
ZIA · FY2016 · CL · contact PI
Randomized informed consent$0
ZIA · FY2016 · CL · contact PI
Parental permission and adolescent assent and decision making in clinical resear$0
ZIA · FY2015 · CL · contact PI
Surrogate Decision Making$0
ZIA · FY2015 · CL · contact PI
Randomized informed consent$0
ZIA · FY2015 · CL · contact PI
Motivations for participation in phase 1 drug development trials$0
ZIA · FY2015 · CL · contact PI
Surrogate Decision Making$0
ZIA · FY2014 · CL · contact PI
Attitudes about payment to research participants$0
ZIA · FY2014 · CL · contact PI
Motivations for participation in phase 1 drug development trials$0
ZIA · FY2014 · CL · contact PI
Consent for oocyte donation$0
ZIA · FY2014 · CL · contact PI
Randomized informed consent$0
ZIA · FY2014 · CL · contact PI
Parental permission and adolescent assent and decision making in clinical resear$0
ZIA · FY2014 · CL · contact PI
Randomized informed consent$0
ZIA · FY2012 · CL · contact PI
Consent for oocyte donation$0
ZIA · FY2012 · CL · contact PI
Motivations for participation in phase 1 drug development trials$0
ZIA · FY2012 · CL · contact PI
Surrogate Decision Making$0
ZIA · FY2012 · CL · contact PI
Parental permission and adolescent assent and decision making in clinical resear$0
ZIA · FY2012 · CL · contact PI
Attitudes about payment to research participants$0
ZIA · FY2012 · CL · contact PI
Parental permission and adolescent assent and decision making in clinical resear$0
ZIA · FY2010 · CL · contact PI
Consent for oocyte donation$0
ZIA · FY2010 · CL · contact PI
Motivations for participation in phase 1 drug development trials$0
ZIA · FY2010 · CL · contact PI
Surrogate Decision Making$0
ZIA · FY2010 · CL · contact PI
Randomized informed consent$0
ZIA · FY2010 · CL · contact PI
Attitudes about payment to research participants$0
ZIA · FY2010 · CL · contact PI
Parental permission and adolescent assent and decision making in clinical resear$0
ZIA · FY2009 · CL · contact PI
Ethical Problems of Registered Nurses and Social Workers$0
ZIA · FY2009 · CL · contact PI
Randomized informed consent$0
ZIA · FY2009 · CL · contact PI
Ethical Problems of Registered Nurses and Social Workers$14,000
Z01 · FY2008 · CL · contact PI
Ethical Problems of Registered Nurses and Social Workers$0
Z01 · FY2004 · CL
Updating Risks and Benefits in Phase I Oncology Trials$0
Z01 · FY2004 · CL
Perceptions Of Benefits And Risks-Rakai$0
Z01 · FY2004 · CL
Ethical Issues With Nurse Practitioner /Physician Assist$0
Z01 · FY2004 · CL
Ethics Substudy Of An Anti-malarial Efficacy Study In Ug$0
Z01 · FY2003 · CL
Perceptions Of Benefits And Risks-Rakai$0
Z01 · FY2003 · CL
Ethical Issues With Nurse Practitioner And Physician Ass$0
Z01 · FY2003 · CL
Ethical Problems of Registered Nurses and Social Workers$0
Z01 · FY2003 · CL
Updating Risks and Benefits in Phase I Oncology Trials$0
Z01 · FY2003 · CL
Perceptions Of Benefits And Risks-Rakai$0
Z01 · FY2002 · CL
Ethical Issues With Nurse Practitioner And Physician Ass$0
Z01 · FY2002 · CL
Ethics Substudy Of An Anti-malarial Efficacy Study In Ug$0
Z01 · FY2002 · CL
Policies And Practices Of Payment To Research Subjects$0
Z01 · FY2001 · CL
Influences On Hiv-infected Subjects$0
Z01 · FY2001 · CL
Influences on HIV-infected Subjects'Willingness to Participate in Research and$0
Z01 · FY2000 · CL
Policies and Practices of Payment to Research Subjects$0
Z01 · FY2000 · CL